Autolus files 8-K/A to furnish Q4 2023 earnings call transcript; no new financial details

Autolus Therapeutics plc

Amendment filed solely to furnish transcript of March 14, 2024 FY2023 earnings call.
The transcript does not contain specific financial data (revenue, EPS, etc.).
Original 8-K with press release remains the source for actual financial results.
No substantive changes were made to the previously filed financial information.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Autolus Therapeutics plc reported financial results for the year ended December 31, 2023.

Period: the year ended December 31, 2023
Result: reported results

Exact text from the filing

On March 14, 2024, the Company held a conference call to discuss its financial results for the year ended December 31, 2023.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

Autolus Therapeutics plc filing history →

Source: SEC EDGAR

accession 0001730463-24-000029

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.